Latest in Schizophrenia Drug Disappoints
Sort by
278 items
-
AbbVie shares tumble after schizophrenia drug disappoints
US pharma group says patients who took Emraclidine in clinical trials failed to show a significant decline in symptomsBusiness - Financial Times - November 11 -
Bristol Myers Squibb’s stock soars after rival AbbVie reports disappointing schizophrenia-drug trial
Bristol Myers Squibb Co. shares surged 12.5% Monday after rival AbbVie Inc. reported disappointing results from the trial of a new schizophrenia drug.Business - MarketWatch - November 11 -
AbbVie’s disappointing schizophrenia drug trial bodes well for rival Bristol Myers, analysts say
AbbVie’s “pain” is Bristol Myers Squibb’s “gain,” says Truist Securities analyst Srikripa Devarakonda.Business - MarketWatch - November 12 -
A promising schizophrenia drug showed mixed results. What does that mean for patients?
Some people who took a new schizophrenia drug for one year improved with only a few side effects, but many dropped out of the researchHealth - ABC News - October 31 -
Lilly’s Mounjaro, Zepbound drugs see strong demand. So why did sales disappoint?
Eli Lilly’s stock heads for biggest selloff in more than three years after sales of anti-obesity drugs Mounjaro and Zepbound came up well short of forecasts.Business - MarketWatch - October 30 -
Saka 'disappointed' after draw with Liverpool
Bukayo Saka became the youngest Arsenal player to score 50 Premier League goals when he returned from a hamstring injury in Sunday's 2-2 draw with Liverpool, but the winger was disappointed to drop ...Sports - ESPN - October 28 -
Wiegman disappointed by Ballon d'Or scheduling
England manager Sarina Wiegman has said it is "really disappointing" that the Ballon d'Or ceremony is once again clashing with the women's international break.Sports - ESPN - October 29 -
Why the Social Media Reaction to Trump’s Election May Be Different From 2016
In 2016, online platforms were awash in calls to protest the day after Donald J. Trump’s victory. On Wednesday, many said it seemed like business as usual.Lifestyle - The New York Times - November 8 -
Drug Overdose Deaths Are Declining Due to Changes in the Drug Supply
Experts are puzzling over which interventions are saving lives. The evolving illicit supply itself may hold important clues.Health - The New York Times - 2 days ago -
AMD reports record revenue but Q4 forecast disappoints
Advanced Micro Devices reported record Q3 revenue of $6.8 billio, up 18%. But the shares fell due to a disappointing forecast for Q4.Tech - VentureBeat - October 29 -
Four Verts: Biggest midseason surprises and disappointments
A fading star QB hasn't resurrected the Jets, while a rising star QB is turbocharging the Commanders. Meanwhile, the Saints are crashing and burning.Sports - Yahoo Sports - November 6 -
The N.F.L.’s Biggest Surprises, and Disappointments, at the Halfway Point
Despite losing their quarterback, the Vikings are on the rise thanks to an outstanding coach, a columnist for The Athletic writes.Sports - The New York Times - November 7 -
Oil ends down on the day, up for the week on conflicting supply-demand prospects
Oil futures finished lower on Friday, with China’s latest round of stimulus measures failing to lift expectations for energy demand in the face of President-elect Donald Trump’s support for more ...Business - MarketWatch - November 8 -
Why the first Sunday of the season won't disappoint
A Final Four rematch. Ashlyn Watkins' return. A new era at Iowa and Virginia Tech. And a court dedication at Maples. Sunday's schedule is must-see.Sports - ESPN - November 10